{
    "code": "02023712",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023712",
    "time": "2019-12-27 03:38:36",
    "許可證字號": "衛署藥輸字第023712號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "112\/05\/05",
    "發證日期": "92\/05\/05",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202371203",
    "中文品名": "威洛速靜脈輸注液４００毫克∕２５０毫升",
    "英文品名": "AVELOX INFUSION SOLUTION 400MG\/250ML",
    "適應症": "用於治療成人(十八歲以上)感受性細菌引起的感染症，包括：上呼吸道及下呼吸道感染(急性鼻竇炎、慢性支氣管的急性惡化、社區性肺炎)，皮膚和軟組織的感染，複雜腹腔內感染(包括多種細菌感染症)。",
    "劑型": "242靜脈點注射劑",
    "包裝": "塑膠軟袋裝 250公撮玻璃瓶裝 瓶塞材質Chlorobutyl stopper:  chlorobutyl gray mat with foil-clad PTFE siliconized type I for infusion (0818 瓶塞材質Bromobutyl stopper: Stopper bromobutyl gray siliconized type I for infusion (0842) 瓶塞材質Bromobutyl stopper: Stopper bromobutyl gray mat siliconized type I for infusion (0844)",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入 52依本署七七公告於國內進行臨床試驗且核定為新藥",
        "申請商名稱": "1426201100  台灣拜耳股份有限公司",
        "申請商地址": "台北市信義區信義路五段7號台北101大樓之53至54樓",
        "主製造廠": ""
    },
    "CCC號列": "30042000916 人用醫藥製劑，含有其他抗生素者Medicaments, containing other antibiotics, for human use",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812700910",
            "成分名稱": "MOXIFLOXACIN HYDROCHLORIDE",
            "含量描述": "",
            "含量": "1.7440000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Avelox Inj_023712_bottle-105-03-18(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023712&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Avelox IV C_CCDS21_TW14_clean_20190806_HH排版-108-09-24.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023712&Seq=044&Type=9"
        },
        {
            "title": "Avelox IV_bottle label (B AG)-107-05-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023712&Seq=005&Type=8"
        },
        {
            "title": "Avelox IV_carton (B AG)-107-05-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023712&Seq=004&Type=8"
        }
    ]
}